泰禾股份：环丙氟虫胺作为公司自主创制的专利产品，毛利率会高于公司现有产品的平均水平

Group 1 - The core product, Baisijia, is a proprietary product developed by the company, indicating a focus on innovation and product differentiation [2] - The gross margin of the new product, Cyproconazole, is expected to exceed the average gross margin of the company's existing products, suggesting potential for improved profitability [2]